On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
Hierarchical Phase-Contrast Tomography (HiP-CT) is a new x-ray tomography technique that spans a previously poorly explored scale in our understanding of human anatomy, the micron to whole intact organ scale. HiP-CT is a propagation-based phase-contrast x-ray imaging technique utilises the higher energies, higher beam coherence and small source size enabled by the Extremely Brilliant Source upgrade of the European Synchrotron Radiation Facility (ESRF-EBS). Using HiP-CT we are developing a ‘Human Organ Atlas’ that bridges the traditional imaging scales of histology (using optical and electron microscopy images cells and other structures with sub-micron accuracy but only on small biopsies of tissue from an organ) to clinical CT and MRI scans (which can image whole organs, but with a resolution only down to just below a millimetre). HiP-CT bridges these scales in 3D, imaging intact organs with ca. 20 micron voxels, and locally down to the micron scale. We hope this open access Atlas, enabled by the ESRF-EBS, will act as a reference to provide new insights into our biological makeup in health and disease. See mecheng.ucl.ac.uk/hip-ct for more details, a list of our publications (e.g. bit.ly/HiP-CT-paper ) and videos seeing inside our organs with near micron resolution (bit.ly/HiP-CT-videos).
The HiP-CT technique was developed to image complete human organs, including those damaged by SARS-CoV-2 infection, through an international collaboration of imaging scientists at University College London and ESRF, working with Clinical scientists treating COVID-19 patients in Hannover, Mainz, Heidelberg and Grenoble, to help understand the disease.